| Novel role for the AnxA1-Fpr2/ALX signaling axis as a key regulator of platelet function to promote resolution of inflammation EY Senchenkova, J Ansari, F Becker, SA Vital, Z Al-Yafeai, ... Circulation 140 (4), 319-335, 2019 | 108 | 2019 |
| Endothelial FN (Fibronectin) deposition by α5β1 integrins drives atherogenic inflammation Z Al-Yafeai, A Yurdagul Jr, JM Peretik, M Alfaidi, PA Murphy, AW Orr Arteriosclerosis, thrombosis, and vascular biology 38 (11), 2601-2614, 2018 | 70 | 2018 |
| Cystathionine γ-lyase modulates flow-dependent vascular remodeling S Yuan, A Yurdagul Jr, JM Peretik, M Alfaidi, Z Al Yafeai, S Pardue, ... Arteriosclerosis, thrombosis, and vascular biology 38 (9), 2126-2136, 2018 | 48 | 2018 |
| Targeting the AnxA1/Fpr2/ALX pathway regulates neutrophil function, promoting thromboinflammation resolution in sickle cell disease J Ansari, EY Senchenkova, SA Vital, Z Al-Yafeai, G Kaur, ... Blood, The Journal of the American Society of Hematology 137 (11), 1538-1549, 2021 | 41 | 2021 |
| Talin-dependent integrin activation is required for endothelial proliferation and postnatal angiogenesis FE Pulous, JC Carnevale, Z Al-Yafeai, BH Pearson, JAG Hamilton, ... Angiogenesis 24, 177-190, 2021 | 27 | 2021 |
| Decreased bioavailability of hydrogen sulfide links vascular endothelium and atrial remodeling in atrial fibrillation M Watts, GK Kolluru, P Dherange, S Pardue, M Si, X Shen, K Trosclair, ... Redox biology 38, 101817, 2021 | 21 | 2021 |
| A case of antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis post COVID-19 vaccination Z Al-Yafeai, BJM Horn, W Terraccaine, A Jose, P Krishnan, BJMJ Horn Cureus 14 (3), 2022 | 9 | 2022 |
| Cardiovascular complications of modern multiple myeloma therapy: A pharmacovigilance study Z Al‐Yafeai, M Ghoweba, A Ananthaneni, H Abduljabar, D Aziz British Journal of Clinical Pharmacology 89 (2), 641-648, 2023 | 8 | 2023 |
| Integrin affinity modulation critically regulates atherogenic endothelial activation in vitro and in vivo Z Al-Yafeai, BH Pearson, JM Peretik, ED Cockerham, KA Reeves, ... Matrix Biology 96, 87-103, 2021 | 5 | 2021 |
| Novel multiple sclerosis agents-associated cardiotoxicity: A real-world pharmacovigilance study Z Al-Yafeai, A Carvajal-González, H Abduljabar, M Arvas, S Patel, N Patel International Journal of Cardiology 362, 153-157, 2022 | 4 | 2022 |
| Adverse events related to AtriCure EPi‐Sense Coagulation Device—Analysis of the FDA MAUDE database AR Sheth, Z Al Yafeai, P Dominic Journal of cardiovascular electrophysiology 33 (2), 151-153, 2022 | 3 | 2022 |
| AHA Journals W Ye, K Steenland, A Quinn, J Liao, K Balakrishnan, G Rosa, ... Hypertension 79 (8), 2022 | 2 | 2022 |
| Cardiovascular complications of modern multiple myeloma therapy: analysis of FDA adverse event reporting system Z Al-Yafeai, A Ananthaneni, M Ghoweba, H Abduljabar, D Aziz, U Grewal MedRxiv, 2021.12. 20.21268138, 2021 | 2 | 2021 |
| Cardiomyopathy-associated hospital admissions among methamphetamine users: geographical and social disparities Z Al-Yafeai, S Ali, J Brown, M Venkataraj, MS Bhuiyan, ASM Faisal, ... JACC: Advances, 100840, 2024 | 1 | 2024 |
| Novel psoriasis agents associated cardiotoxicity: analysis of FAERS R Vyas, Z Al-Yafeai, M Sondhi, K Vadlamudi Circulation 148 (Suppl_1), A16751-A16751, 2023 | 1 | 2023 |
| Vaccines and Atrial Fibrillation: A Real-World Pharmacovigilance Study Based on Vaccine Adverse Event Reporting System Z Al-Yafeai, M Ghoweba, D Aziz, A Ananthaneni, MD Sabayon American Journal of Therapeutics 30 (2), 151-153, 2023 | 1 | 2023 |
| Quantification of integrin activation and ligation in adherent cells Z Al-Yafeai, AW Orr The Integrin Interactome: Methods and Protocols, 17-25, 2021 | 1 | 2021 |
| TEE SAVES THE DAY; A TEAR THAT ALMOST GOT AWAY J Taylor, Z Al-Yafeai, MM Kansal Journal of the American College of Cardiology 83 (13_Supplement), 4094-4094, 2024 | | 2024 |
| Novel anti-psoriasis agent-associated cardiotoxicity, analysis of the FDA adverse event reporting system (FAERS) Z Al-Yafeai, M Sondhi, K Vadlamudi, R Vyas, D Nadeem, M Alawadi, ... International Journal of Cardiology, 131819, 2024 | | 2024 |
| Immunosuppressant Drug-Associated Non-Hodgkin Lymphoma: A Real-World Pharmacovigilance Database Analysis A Ananthaneni, D Heap, F Weis, S Chowdary, R Sam, Z Al-Yafeai, ... Blood 142 (Supplement 1), 6268-6268, 2023 | | 2023 |
A. Wayne OrrProfessor and Director, Division of Research, Dept. of Pathology, LSU Health Science CenterVerified email at lsuhsc.edu
